Analysis Biomolecular Interactions of Neutralizing Antibody (NAb) CAP256LS with HIV-1 Envelope V1V2 Site by BLI (CAT#: STEM-MB-0145-CJ)

Introduction

A neutralizing antibody (NAb) is an antibody that is responsible for defending cells from pathogens, which are organisms that cause disease. They are produced naturally by the body as part of its immune response, and their production is triggered by both infections and vaccinations against infections. CAP256-VRC26.25 (abbreviated CAP256LS) is a human IgGI monoclonal antibody targeting the V1V2 site of the HIV-1 envelope. It can be used as a broadly neutralizing HIV-1 monoclonal antibody with promising therapeutic potential.The region consisting of the first and second variable regions (V1V2) of gp120 plays vital roles in the functioning of the HIV-1 envelope (Env). V1V2, which harbors multiple glycans and is highly sequence diverse, is located at the Env apex and stabilizes the trimeric gp120 spike on the virion surface.

Add to Cart Please Inquire

Principle Applications Procedure Materials Notes Related Products

Principle

Bio-Layer Interferometry (BLI) is an optical technique for measuring macromolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. BLI experiments are used to determine the kinetics and affinity of molecular interactions. In a BLI experiment, one molecule is immobilized to a Dip and Read Biosensor and binding to a second molecule is measured. A change in the number of molecules bound to the end of the biosensor tip causes a shift in the interference pattern that is measured in real-time.

Applications

Immunology/Inflammation; Virology; Pharmacology

Procedure

1. Detect Buffers and prepare samples. BLI experiments are set up with one molecule immobilised on the surface of the biosensor (load sample) and a second molecule in solution (the analytical sample).
2. Fix the load sample on the biocompatible biosensor while the analytical sample is in solution.
3. The biosensor tip is immersed in the solution so that the target molecule begins to bind to the analysis sample.
4. Set up and run the BLI experiment. Molecules bound to or dissociated from the biosensor can generate response curves on the BLI system; unbound molecules, changes in the refractive index of the surrounding medium or changes in flow rate do not affect the interferogram pattern.
5. Collect and analyse data on the BLI's system.

Materials

• Equipment: Bio-Layer Interferometry (BLI)
• Sample Type: DNA, RNA, Protein, Antibodies, Peptides, Small Molecules

Other recommended products

Analysis Biomolecular Interactions of Protein with Histone Peptides by BLI (CAT#: STEM-MB-0092-CJ)
Analysis Kinetics of IL-8 Protein by KinExA (CAT#: STEM-MB-0263-CJ)
Analysis Biomolecular Interactions of PirA and PII from Synechocystis by BLI (CAT#: STEM-MB-0176-CJ)
Analysis Biomolecular Interactions of Antibodies with Purified Stx2a Protein by BLI (CAT#: STEM-MB-0151-CJ)
Analysis Kinetics of Domoic Acid (DA) by BLI (CAT#: STEM-MB-0282-CJ)
Analysis Biomolecular Interactions of Antibody with Various P[8] Molecules by BLI (CAT#: STEM-MB-0116-CJ)
Analysis Biomolecular Interactions of Oligomeric Variants of GFPp_FGF1 with FGFR1ecd-Fc by BLI (CAT#: STEM-MB-0192-CJ)
Analysis Biomolecular Interactions of Protein-Nucleic Acid by BLI (CAT#: STEM-MB-0088-CJ)